Skip to main content
TipRanks
Go Ultimate75% OFF

Q32 Bio (0T6G) Financial Statements

1 Followers

Q32 Bio Financial Overview

Q32 Bio's market cap is currently $249.57M. The company's EPS TTM is $3.13; its P/E ratio is 2.66; and it has a dividend yield of 0.46%. Q32 Bio is estimated to report earnings on March 16, 2027, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 53.74M$ 0.00$ -6.65M$ 6.65M$ 0.00
Gross Profit$ 53.74M$ 0.00$ -6.65M$ 6.65M$ 0.00
Operating Income$ 16.90M$ -66.10M$ -48.26M$ -39.23M$ -36.69M
EBITDA$ 31.31M$ -44.50M$ -47.76M$ -38.85M$ -27.15M
Net Income$ 29.82M$ -47.73M$ -53.74M$ -42.81M$ -37.56M
Balance Sheet
Cash & Short-Term Investments$ 48.30M$ 77.97M$ 25.62M$ 175.03M$ 155.87M
Total Assets$ 61.78M$ 92.33M$ 47.06M$ 229.53M$ 211.72M
Total Debt$ 15.34M$ 18.90M$ 50.84M$ 29.95M$ 23.93M
Net Debt$ -32.95M$ -59.06M$ 25.22M$ -4.04M$ -84.45M
Total Liabilities$ 19.76M$ 86.66M$ 229.98M$ 51.54M$ 42.07M
Stockholders' Equity$ 42.01M$ 5.67M$ -182.92M$ 177.98M$ 169.65M
Cash Flow
Free Cash Flow$ -33.54M$ -67.79M$ -18.68M$ -13.44M$ -112.15M
Operating Cash Flow$ -33.54M$ -67.72M$ -18.68M$ -10.96M$ -109.75M
Investing Cash Flow$ 7.00M$ 19.93M$ -5.00K$ -2.47M$ -50.79M
Financing Cash Flow$ -3.13M$ 95.14M$ 406.00K$ 30.07M$ 52.17M

Currency in USD

Q32 Bio Earnings and Revenue History

-160M-80M080M-8000 %-4000 %0 %4000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Q32 Bio Liabilities to Assets

0120M240M360M0 %200 %400 %600 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Q32 Bio Cash Flow

-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing

Q32 Bio Forecast EPS vs Actual EPS

-20246Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss